Stock PCSA PROCESSA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Processa Pharmaceuticals, Inc.

Equities

PCSA

US74275C3043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.48 USD -3.90% Intraday chart for Processa Pharmaceuticals, Inc. -17.78% -77.88%
May. 10 Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 Processa Pharmaceuticals, Inc. Names Steven Cha as Senior Vice President of Clinical Research CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROCESSA PHARMACEUTICALS, INC. Stock Processa Pharmaceuticals, Inc.
 4.23M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. PCSA Stock
  4. Charts Processa Pharmaceuticals, Inc.
  5. Sector Chart